Mei Hong

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 20, 2023
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.

Yi Zhang, Hu Zhou, Minghui Duan

Pageof 1

Frequent Collaborators

1 joint publications

Yi Zhang

1 joint publications

Minghui Duan

1 joint publications

Guangsheng He

1 joint publications

Huanling Zhu